Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/543125]Researchers: Dr Pantelis Poumbourios (Principal investigator) , A/Pr Heidi Drummer , Prof Matthew Wilce
Brief description Approximately 40 million individuals are currently living with HIV. The viral glycoproteins, gp120-gp41, mediate the first stage of infection, membrane fusion, and thus serve as targets for vaccines and antiviral agents. Thi proposal seeks to assess the structure and function of a potential new drug target in gp120-gp41. These studies may lead to the identification of a new antiviral that blocks membrane fusion. Such agents can be added to antiviral drug cocktails for more effective therapy.
Funding Amount $AUD 529,632.69
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- nhmrc : 543125
- PURL : https://purl.org/au-research/grants/nhmrc/543125
